Mirae Asset Global Investments Co. Ltd. Purchases 18,164 Shares of DaVita Inc. (NYSE:DVA)

Mirae Asset Global Investments Co. Ltd. lifted its stake in shares of DaVita Inc. (NYSE:DVA - Free Report) by 291.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 24,388 shares of the company's stock after acquiring an additional 18,164 shares during the period. Mirae Asset Global Investments Co. Ltd.'s holdings in DaVita were worth $3,664,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. UMB Bank n.a. grew its stake in shares of DaVita by 65.5% during the 1st quarter. UMB Bank n.a. now owns 192 shares of the company's stock worth $29,000 after acquiring an additional 76 shares in the last quarter. Copia Wealth Management acquired a new position in DaVita during the fourth quarter worth $30,000. SBI Securities Co. Ltd. acquired a new stake in DaVita in the 4th quarter valued at $41,000. Coppell Advisory Solutions LLC lifted its position in DaVita by 50.0% during the 4th quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company's stock worth $45,000 after buying an additional 100 shares in the last quarter. Finally, Canada Post Corp Registered Pension Plan acquired a new position in shares of DaVita during the 4th quarter worth about $55,000. 90.12% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

DVA has been the topic of several analyst reports. Truist Financial dropped their target price on DaVita from $170.00 to $164.00 and set a "hold" rating on the stock in a report on Monday, May 19th. Wall Street Zen raised DaVita from a "hold" rating to a "buy" rating in a report on Friday, April 25th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $164.50.

DaVita Stock Performance

Shares of DVA remained flat at $142.56 during mid-day trading on Thursday. The stock had a trading volume of 600,082 shares, compared to its average volume of 808,371. The company has a current ratio of 1.25, a quick ratio of 1.20 and a debt-to-equity ratio of 23.18. DaVita Inc. has a 52 week low of $131.76 and a 52 week high of $179.60. The business's fifty day moving average price is $139.94 and its 200-day moving average price is $149.32. The stock has a market cap of $10.76 billion, a PE ratio of 14.13, a P/E/G ratio of 1.01 and a beta of 1.11.

DaVita (NYSE:DVA - Get Free Report) last announced its quarterly earnings results on Monday, May 12th. The company reported $2.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.75 by $0.25. DaVita had a return on equity of 176.11% and a net margin of 6.63%. The business had revenue of $3.22 billion during the quarter, compared to the consensus estimate of $3.22 billion. During the same quarter last year, the firm posted $2.26 EPS. The company's quarterly revenue was up 5.0% on a year-over-year basis. Research analysts anticipate that DaVita Inc. will post 10.76 EPS for the current year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.